Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 01-2022 | 10-2021 | 07-2021 | 04-2021 | |
| Sales | 458 | 0 | 0 | 250 | 1,375 |
| Cost of Goods | 368 | N/A | N/A | N/A | N/A |
| Gross Profit | 90 | N/A | N/A | 250 | 1,375 |
| Operating Expenses | 10,304 | 4,164 | 0 | 4,381 | 7,696 |
| Operating Income | -9,846 | -4,164 | N/A | -4,131 | -6,321 |
| Other Income | 82 | 3,799 | 0 | 847 | 1,214 |
| Pre-tax Income | -9,764 | -365 | 0 | -3,284 | -5,107 |
| Income Tax | 189 | N/A | N/A | 50 | N/A |
| Net Income Continuous | -9,953 | -365 | N/A | -3,334 | -5,107 |
| Net Income | $-9,953 | $-365 | $N/A | $-3,334 | $-5,107 |
| EPS Basic Total Ops | -3.47 | 0.00 | N/A | -1.83 | -3.32 |
| EPS Basic Continuous Ops | -3.47 | -0.20 | N/A | -1.83 | -3.32 |
| EPS Diluted Total Ops | -3.47 | 0.00 | N/A | -1.83 | -3.32 |
| EPS Diluted Continuous Ops | -3.47 | -0.20 | N/A | -1.83 | -3.32 |
| EPS Diluted Before Non-Recurring Items | -1.90 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-9,647 | $-3,965 | $N/A | $-3,992 | $-5,928 |